A short review on the psychoneuroimmunology of posttraumatic stress disorder: From risk factors to medical comorbidities

Brain, Behavior, and Immunity

Volumn 25, Issue 1, 2011, Pages 6-13

  Pace, Thaddeus W W ^a   Heim, Christine M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catecholamines; Glucocorticoids; Immune system; Inflammation; Neuroendocrine immune interactions; PTSD; PTSD risk factors

Indexed keywords

CATECHOLAMINE; CYTOKINE; GLUCOCORTICOID;

B LYMPHOCYTE; CELL COUNT; COMORBIDITY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; INFLAMMATION; MONOCYTE; NATURAL KILLER CELL; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN TEST; STRESS; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION MEDIATORS; NEUROSECRETORY SYSTEMS; PSYCHONEUROIMMUNOLOGY; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 78649324180     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.003     Document Type: Review

References (71)

1. Altemus M., Dhabhar F.S., Yang R. Immune function in PTSD. Ann. NY Acad. Sci. 2006, 1071:167-183.
2. Baker D.G., Ekhator N.N., Kasckow J.W., Hill K.K., Zoumakis E., Dashevsky B.A., Chrousos G.P., Geracioti T.D. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. NeuroImmunoModulation 2001, 9:209-217.
3. Bedi U.S., Arora R. Cardiovascular manifestations of posttraumatic stress disorder. J. Natl. Med. Assoc. 2007, 99:642-649.
4. Bichescu D., Schauer M., Saleptsi E., Neculau A., Elbert T., Neuner F. Long-term consequences of traumatic experiences: an assessment of former political detainees in Romania. Clin. Pract. Epidemiol. Ment. Health 2005, 1:17.
5. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl Acad. Sci. USA 2003, 100:1920-1925.
6. Boscarino J.A. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann. NY Acad. Sci. 2004, 1032:141-153.
7. Boscarino J.A. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom. Med. 2008, 70:668-676.
8. Boscarino J.A., Chang J. Higher abnormal leukocyte and lymphocyte counts 20 years after exposure to severe stress: research and clinical implications. Psychosom. Med. 1999, 61:378-386.
9. Boscarino J.A., Forsberg C.W., Goldberg J. A twin study of the association between PTSD symptoms and rheumatoid arthritis. Psychosom. Med. 2010, 72:481-486.
10. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., Nemeroff C.B., Charney D.S. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 1997, 154:624-629.
11. Bremner J.D., Elzinga B., Schmahl C., Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog. Brain Res. 2008, 167:171-186.
12. Danese, A., Caspi, A., Williams, B., Ambler, A., Sugden, K., Mika, J., Werts, H., Freeman, J., Pariante, C.M., Moffitt, T.E., Arseneault, L., 2010. Biological embedding of stress through inflammation processes in childhood. Mol. Psychiatry, in press.
13. Danik J.S., Ridker P.M. Genetic determinants of C-reactive protein. Curr. Atheroscler. Rep. 2007, 9:195-203.
14. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G., Heijnen C.J. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry 2007, 12:443-453.
15. Garcia-Linares M.I., Sanchez-Lorente S., Coe C.L., Martinez M. Intimate male partner violence impairs immune control over herpes simplex virus type 1 in physically and psychologically abused women. Psychosom. Med. 2004, 66:965-972.
16. Geracioti T.D., Baker D.G., Ekhator N.N., West S.A., Hill K.K., Bruce A.B., Schmidt D., Rounds-Kugler B., Yehuda R., Keck P.E., Kasckow J.W. CSF norepinephrine concentrations in posttraumatic stress disorder. Am. J. Psychiatry 2001, 158:1227-1230.
17. Gill J.M., Saligan L., Woods S., Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 2009, 45:262-277.
18. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
19. Gotovac K., Vidovic A., Vukusic H., Krcmar T., Sabioncello A., Rabatic S., Dekaris D. Natural killer cell cytotoxicity and lymphocyte perforin expression in veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:597-604.
20. Graham J.E., Robles T.F., Kiecolt-Glaser J.K., Malarkey W.B., Bissell M.G., Glaser R. Hostility and pain are related to inflammation in older adults. Brain Behav. Immun. 2006, 20:389-400.
21. Heim C., Mletzko T., Purselle D., Musselman D.L., Nemeroff C.B. The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol. Psychiatry 2008, 63:398-405.
22. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009, 14:13-24.
23. Heppner P.S., Crawford E.F., Haji U.A., Afari N., Hauger R.L., Dashevsky B.A., Horn P.S., Nunnink S.E., Baker D.G. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med. 2009, 7:1.
24. Inoue-Sakurai C., Maruyama S., Morimoto K. Posttraumatic stress and lifestyles are associated with natural killer cell activity in victims of the Hanshin-Awaji earthquake in Japan. Prev. Med. 2000, 31:467-473.
25. Ironson G., Wynings C., Schneiderman N., Baum A., Rodriguez M., Greenwood D., Benight C., Antoni M., LaPerriere A., Huang H.S., Klimas N., Fletcher M.A. Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom. Med. 1997, 59:128-141.
26. Kawamura N., Kim Y., Asukai N. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am. J. Psychiatry 2001, 158:484-486.
27. Keane T.M., Marshall A.D., Taft C.T. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu. Rev. Clin. Psychol. 2006, 2:161-197.
28. Kessler R.C. Posttraumatic stress disorder: the burden to the individual and to society. J. Clin. Psychiatry 2000, 61(Suppl. 5):4-12. Discussion 13-14.
29. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
30. Kibler J.L. Posttraumatic stress and cardiovascular disease risk. J. Trauma Dissociation 2009, 10:135-150.
31. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. USA 2010, 107:2669-2674.
32. Kosor Krnic E., Gagro A., Kozaric-Kovacic D., Vilibic M., Grubisic-Ilic M., Folnegovic-Smalc V., Drazenovic V., Cecuk-Jelicic E., Gjenero-Margan I., Kuzman I., Jeren T., Sabioncello A., Kerhin-Brkljacic V., Kaic B., Markotic A., Gotovac K., Rabatic S., Mlinaric-Galinovic G., Dekaris D. Outcome of influenza vaccination in combat-related post-traumatic stress disorder (PTSD) patients. Clin. Exp. Immunol. 2007, 149:303-310.
33. Kunz-Ebrecht S.R., Mohamed-Ali V., Feldman P.J., Kirschbaum C., Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav. Immun. 2003, 17:373-383.
34. Laudenslager M.L., Aasal R., Adler L., Berger C.L., Montgomery P.T., Sandberg E., Wahlberg L.J., Wilkins R.T., Zweig L., Reite M.L. Elevated cytotoxicity in combat veterans with long-term post-traumatic stress disorder: preliminary observations. Brain Behav. Immun. 1998, 12:74-79.
35. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 1999, 45:833-839.
36. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry 2007, 191:387-392.
37. Miller A.H. Depression and immunity: a role for T cells?. Brain Behav. Immun. 2010, 24:1-8.
38. Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom. Med. 2008, 70:298-305.
39. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72:219-246.
40. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., Lazaropoulou C., Papassotiriou I., Tsiantis J., Chrousos G.P. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999.
41. Pole N., Neylan T.C., Otte C., Henn-Hasse C., Metzler T.J., Marmar C.R. Prospective prediction of posttraumatic stress disorder symptoms using fear potentiated auditory startle responses. Biol. Psychiatry 2009, 65:235-240.
42. Qureshi S.U., Pyne J.M., Magruder K.M., Schulz P.E., Kunik M.E. The link between post-traumatic stress disorder and physical comorbidities: a systematic review. Psychiatr. Q. 2009, 80:87-97.
43. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
44. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 2004, 55:745-751.
45. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
46. Sabioncello A., Kocijan-Hercigonja D., Rabatic S., Tomasic J., Jeren T., Matijevic L., Rijavec M., Dekaris D. Immune, endocrine, and psychological responses in civilians displaced by war. Psychosom. Med. 2000, 62:502-508.
47. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
48. Skarpa I., Rubesa G., Moro L., Manestar D., Petrovecki M., Rukavina D. Changes of cytolytic cells and perforin expression in patients with posttraumatic stress disorder. Croat. Med. J. 2001, 42:551-555.
49. Sommershof A., Aichinger H., Engler H., Adenauer H., Catani C., Boneberg E.M., Elbert T., Groettrup M., Kolassa I.T. Substantial reduction of naive and regulatory T cells following traumatic stress. Brain Behav. Immun. 2009, 23:1117-1124.
50. Sondergaard H.P., Hansson L.O., Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin. Chim. Acta 2004, 342:93-98.
51. Spitzer C., Barnow S., Volzke H., Wallaschofski H., John U., Freyberger H.J., Lowe B., Grabe H.J. Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. J. Psychiatr. Res. 2010, 44:15-21.
52. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., Weizman A. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol. Psychiatry 1997, 42:345-348.
53. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 2009, 78:539-552.
54. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 1997, 27:951-959.
55. Sundin J., Fear N.T., Iversen A., Rona R.J., Wessely S. PTSD after deployment to Iraq: conflicting rates, conflicting claims. Psychol. Med. 2010, 40:367-382.
56. Tousoulis D., Antoniades C., Koumallos N., Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev. 2006, 17:225-233.
57. Tucker P., Jeon-Slaughter H., Pfefferbaum B., Khan Q., Davis N.J. Emotional and biological stress measures in Katrina survivors relocated to Oklahoma. Am. J. Disaster. Med. 2010, 5:113-125.
58. Uddin M., Aiello A.E., Wildman D.E., Koenen K.C., Pawelec G., de Los Santos R., Goldmann E., Galea S. Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc. Natl. Acad. Sci. USA 2010, 107:9470-9475.
59. van Zuiden M., Heijnen C.J., Geuze E., Willemen H., Maas M., Vermetten E., Kavelaars A. Increased glucocorticoid binding to peripheral blood mononuclear cells before military deployment in individuals developing PTSD symptoms 6 months after deployment. Brain Behav. Immun. 2010, 24:S9-S10.
60. Vidovic A., Vilibic M., Sabioncello A., Gotovac K., Rabatic S., Folnegovic-Smalc V., Dekaris D. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study. Croat. Med. J. 2007, 48:198-206.
61. Vieweg W.V., Julius D.A., Fernandez A., Beatty-Brooks M., Hettema J.M., Pandurangi A.K. Posttraumatic stress disorder: clinical features, pathophysiology, and treatment. Am. J. Med. 2006, 119:383-390.
62. von Känel R., Begre S., Abbas C.C., Saner H., Gander M.L., Schmid J.P. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. NeuroImmunoModulation 2010, 17:39-46.
63. von Känel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., Schnyder U. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. Psychiatr. Res. 2007, 41:744-752.
64. Vythilingam M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., Brummer M., Staib L., Vermetten E., Charney D.S., Nemeroff C.B., Bremner J.D. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am. J. Psychiatry 2002, 159:2072-2080.
65. Wessa M., Rohleder N. Endocrine and inflammatory alterations in post-traumatic stress disorder. Expert Rev. Endocrinol. Metab. 2007, 2:91-122.
66. Wilson S.N., van der Kolk B., Burbridge J., Fisler R., Kradin R. Phenotype of blood lymphocytes in PTSD suggests chronic immune activation. Psychosomatics 1999, 40:222-225.
67. Woods A.B., Page G.G., O'Campo P., Pugh L.C., Ford D., Campbell J.C. The mediation effect of posttraumatic stress disorder symptoms on the relationship of intimate partner violence and IFN-gamma levels. Am. J. Community Psychol. 2005, 36:159-175.
68. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann. NY Acad. Sci. 2009, 1179:56-69.
69. Yehuda R., LeDoux J. Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 2007, 56:19-32.
70. Yehuda R., Siever L.J., Teicher M.H., Levengood R.A., Gerber D.K., Schmeidler J., Yang R.K. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol. Psychiatry 1998, 44:56-63.
71. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994, 643:40-49.